Home » Topics » Regulatory

Regulatory
RSS

FDA approves Zoloft for premenstrual dysphoric disorder

May 22, 2002

E.U. approval for Avonex for early use in high-risk MS patients

May 21, 2002

Actonel 35 mg approved for once-weekly dosing in postmenopausal osteoporosis

May 21, 2002

Paxil approved in Canada for posttraumatic stress disorder

May 17, 2002

Tacrolimus for psoriasis scheduled for marketing within three to four years

May 10, 2002

Positive pharmacokinetic results for buccal desmopressin

May 10, 2002

IND submitted for nitroglycerin lingual spray

May 10, 2002

Avalox i.v. cleared for market introduction in Germany

May 8, 2002

Protonix delayed-release tablets approved for long-term treatment of Zollinger-Ellison syndrome

May 7, 2002

Generex completes proof-of-concept study for buccal fentanyl citrate

May 6, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...